What is a tumor board and should my case be reviewed by one

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Tumor Boards

What Is a Tumor Board?

A tumor board (also called a multidisciplinary tumor conference or cancer conference) is a meeting where a team of cancer specialists from different fields reviews individual patient cases together. The team typically includes:

  • Oncologists (medical, surgical, and radiation specialists)
  • Pathologists (who analyze tissue samples)
  • Radiologists (who interpret imaging like CT scans and MRIs)
  • Surgeons (from relevant specialties)
  • Nurses and other specialists (depending on the cancer type)

During these meetings, the team discusses your [ID removed] test results, imaging, and pathology reports. They collaborate to:

  • Confirm the diagnosis
  • Discuss treatment options and their pros/cons
  • Recommend an integrated treatment plan
  • Identify clinical trials you might be eligible for
  • Address complex or unusual cases

Think of it as getting a "second opinion from multiple experts at once" rather than seeing each specialist individually.

Should Your Case Be Reviewed?

Yes—tumor board review is considered standard practice for most cancer cases. According to the American Cancer Society and NCCN (National Comprehensive Cancer Network) Guidelines, multidisciplinary review is recommended for:

  • New cancer diagnoses (especially if treatment planning is complex)
  • Advanced or metastatic cancers (cancer that has spread)
  • Unusual or rare cancers
  • Cases where treatment decisions are unclear
  • Before major surgery or intensive treatment

Questions to Ask Your Care Team

  1. "Has my case been reviewed by a tumor board, or will it be?"
  2. "Who are the specialists involved in my care planning?"
  3. "If my case hasn't been reviewed yet, can it be presented at the next tumor board meeting?"
  4. "What treatment recommendations came out of the tumor board discussion?"
  5. "Are there any alternative treatment approaches the team discussed?"

How to Request a Tumor Board Review

If your oncologist hasn't mentioned tumor board review, you can:

  • Ask directly: "I'd like my case reviewed by a multidisciplinary team"
  • Request it in writing if needed
  • Ask if your hospital/cancer center has a tumor board (most major cancer centers do)

Most cancer centers automatically present new cases, but it never hurts to confirm.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2

It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated

Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter